Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Infect Dis ; 100: 396-401, 2020 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-32950736

RESUMO

OBJECTIVES: The aim of this study is to determine the optimal duration of antimicrobial therapy for lower respiratory tract infection (LRTI) in neuromuscular disorder (NMD) patients. METHODS: This prospective study included 13 episodes from 9 NMD patients hospitalized for bacterial LRTI. Sputum samples were collected from these patients during the three consecutive days after their admission. Bacterial cell counts and the proportion of the most predominant bacterium identified by a clone library analysis of the bacterial 16S rRNA gene sequence in the samples obtained before antimicrobial therapy were serially investigated. RESULTS: All episodes were initially treated with ampicillin/sulbactam. In 12 episodes with a therapeutic effect, the bacterial cell counts in the samples obtained on the third day of therapy were significantly lower than those before therapy (P = 0.0013). In most of these episodes, the most predominant bacterium in the sample obtained before therapy was undetectable by the third day of therapy. In the one patient without a therapeutic effect, neither the bacterial cell counts nor the proportion of the most predominant bacterium in the sample obtained before therapy decrease after therapy. CONCLUSION: Short-term antimicrobial therapy is sufficiently effective for LRTI in NMD patients if the initial therapy is effective.


Assuntos
Antibacterianos/uso terapêutico , Bactérias/isolamento & purificação , Infecções Bacterianas/tratamento farmacológico , Doenças Neuromusculares/complicações , Infecções Respiratórias/tratamento farmacológico , Adolescente , Adulto , Ampicilina/uso terapêutico , Bactérias/classificação , Bactérias/efeitos dos fármacos , Bactérias/genética , Infecções Bacterianas/etiologia , Infecções Bacterianas/microbiologia , Criança , Pré-Escolar , DNA Bacteriano/genética , Duração da Terapia , Feminino , Humanos , Masculino , Estudos Prospectivos , RNA Ribossômico 16S/genética , Infecções Respiratórias/etiologia , Infecções Respiratórias/microbiologia , Escarro/microbiologia , Sulbactam/uso terapêutico , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...